Latest filing published 14 Jun 2022 for LifeStance Health Group, Inc., €1.7M.
Filing timeline
BuySaleInsider track record
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
No signal scores available.
Michael K. Lester: trading record in brief
Michael K. Lester (chief executive) discloses dealings in LifeStance Health Group, Inc. to SEC (Form 4). The record holds 2 filings, for trades running from 25 April 2022 to 13 June 2022.
Sales make up the whole of the open-market record (1 sale, €1.7M). The rest of the record consists of 1 share grant.
On 14 June 2022 came the latest disclosure, an open-market sale for €1.7M in LifeStance Health Group, Inc. Keep in mind that insiders sell for many reasons unrelated to the outlook, from tax bills to estate planning. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.
Companies and markets linked to Michael K. Lester
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 328,615 shares@ US$5.33100.0% of flowCommon StockSEC:0000899243-22-022393:0
- 289,080 shares0Common StockSEC:0000899243-22-015672:0
2 of 2 declarations
